Dismal response to high-dose methylprednisolone after failure to respond to standard dose in patients with acute GVHD.

about

Dismal response to high-dose methylprednisolone after failure to respond to standard dose in patients with acute GVHD.

Item

http://www.wikidata.org/entity/Q43140213

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Dismal response to high-dose m ...... e in patients with acute GVHD.

@en

Dismal response to high-dose m ...... e in patients with acute GVHD.

@nl

type

Item

label

Dismal response to high-dose m ...... e in patients with acute GVHD.

@en

Dismal response to high-dose m ...... e in patients with acute GVHD.

@nl

prefLabel

Dismal response to high-dose m ...... e in patients with acute GVHD.

@en

Dismal response to high-dose m ...... e in patients with acute GVHD.

@nl

P1476

Dismal response to high-dose m ...... se in patients with acute GVHD

@en

P2093

A Gassas

http://www.w3.org/2001/XMLSchema#string

C Macartney

http://www.w3.org/2001/XMLSchema#string

J Doyle

http://www.w3.org/2001/XMLSchema#string

M Husain

http://www.w3.org/2001/XMLSchema#string

T Schechter

http://www.w3.org/2001/XMLSchema#string

Y Finkelstein

http://www.w3.org/2001/XMLSchema#string

P2860

Endpoints for clinical trials testing treatment of acute graft-versus-host disease: a joint statement

Steroid-refractory graft-vs.-host disease: past, present and future.

Management of acute graft versus host disease (GvHD).

How I treat refractory acute GVHD.

Chronic graft-versus-host disease: implications of the National Institutes of Health consensus development project on criteria for clinical trials.

Bone-marrow transplantation (second of two parts).

A high-dose pulse steroid regimen for controlling active chronic graft-versus-host disease.

Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems.

Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti-thymocyte globulin.

Therapeutically targeting lymphocyte energy metabolism by high-dose glucocorticoids.

P2888

bmt.2010.47

P304

1749-1753

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2010.47

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

L Lee Dupuis

P577

2010-03-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41809188

http://www.w3.org/2001/XMLSchema#string

P6179

1046472393

http://www.w3.org/2001/XMLSchema#string

P698

20208573

http://www.w3.org/2001/XMLSchema#string